Navigation Links
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
Date:5/14/2013

ps with academic research institutions on behalf of pharmaceutical companies. We also discuss the unsustainability of the current drug research model, and the industry's attempts at moving toward an open R&D ecosystem.

Highlights

Key Questions Answered

- What are the reasons for increased activity in strategic deals with academia by leading pharmaceutical companies and promising biotechs?
- What are the deal terms of these collaboration agreements?
- What therapeutic areas and geographic markets are pharmaceutical companies targeting to partner with academic research institutions?
- What proprietary platforms and enabling technologies are these pharmaceutical companies trying to access?

Key Findings

- With the patent cliff and high R&D costs eroding corporate profitability, pharmaceutical companies will look for ways to replenish their pipelines by reaching out to academia in search of novel drug platforms
- Despite the FDA approving 39 new drugs in 2012, the innovation gap continues, as many of these medicines are 'me-too' drugs, or orphan drugs indicated to treat small segments of the population suffering from rare diseases
- Difficulty accessing capital and the continued economic recession have led to a deal adverse environment resulting in deals to decline on a global basis
- Oncology, CNS, immunology and infectious diseases still remain hot therapeutic areas to strike licensing deals with academia

Scope

- Full examination of 25 significant technology transfer deals from 2012 and 2013 involving large pharmaceutical companies and academic organizations including licensing structure and terms
- Analysis of the key drivers, trends, and strategies behind the deals undertaken by these pharmaceutical companies across major therapeutic areas
- Discussion of the unsustainability of the current drug research model and how Big Pharma's embrace of collaboration and an open ecos
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases
2. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
3. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
6. Sigma-Aldrich Launches Novel Search Engine for Peer-Reviewed Literature, Biological Pathway Data and Technology Queries
7. United Spinal Secures Victory in Protecting Access to Complex Rehab Technology in Washington State
8. Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting
9. Plandai Biotechnology, Inc. Announces Formation Of New Entity To Develop Pharmaceutical Applications
10. CooperVision Launches Science and Technology (S&T) Awards Program
11. Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014  Valeant Pharmaceuticals International, ... that its wholly owned subsidiary, Valeant Pharmaceuticals International, will ... amount of its 6.75% Senior Notes due 2017, CUSIP ... 15, 2014 and has mailed an irrevocable notice of ... 2014, a copy of the irrevocable notice of redemption ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne ... ambulance transport services, has been selected by Inc. ... companies in America. Photo - ... Inc. 500|5000 list identifies successful, privately-held companies with ... MedicOne Medical Response, one of only two ambulance ...
(Date:9/15/2014)...  Catalist-listed QT Vascular Ltd. ("QT Vascular" or together ... of minimally invasive medical devices for the treatment of ... has enrolled the first European patients in the ENDURE ... have already been enrolled in this study with Dr. ... Auckland, New Zealand . ...
Breaking Medicine Technology:Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5
(Date:9/15/2014)... Palo Alto, CA (PRWEB) September 15, 2014 ... seventh anniversary since its founding in 2007. To mark ... the local community for supporting the village and helping ... Village provides a safe, secure and fun community for ... connected to the community and live in their own ...
(Date:9/15/2014)... By Dennis Thompson ... (HealthDay News) -- The severe respiratory virus believed to ... Western states has now spread to the Northeast, health ... Health confirmed on Friday more than a dozen cases ... especially for children with asthma. And on Saturday, ...
(Date:9/15/2014)... shown that certain brain regions are associated with ... decision-making. , How and where these specific abilities ... cognition is still under investigation. However, researchers at ... St. Louis, Missouri, believe that several hub regions ... function as an integrated network. , In research ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 According to ... "Spectrometry Market - Global Industry Analysis, Size, Share, Growth, ... market was valued at USD 12,212.9 million in 2013 ... 2020 at a CAGR of 7.2% from 2014 to ... access properties of light within specific electromagnetic spectrum to ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Physicians ... this week, September 17-20, at the Lowes Coronado ... Plant-based Nutrition Healthcare Conference . This CME ... dietary-related advice—our physicians and healthcare professionals—about the nutritional ... food, plant-based nutrition and its proven ability to ...
Breaking Medicine News(10 mins):Health News:Avenidas Village Celebrates Anniversary 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Network measures predict neuropsychological outcome after brain injury 2Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 2Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 3Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 4Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 5Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3
... (NIH) will commit roughly $60 million from American Recovery ... meet objectives set forth earlier this year by a ... largest funding opportunity for research on autism spectrum disorders ... represents a surge in NIH,s commitment to finding the ...
... RICHMOND, Va. (March 24, 2009) Virginia Commonwealth University ... with hearing loss actually re-route the sense of touch ... the study, published online in the Early Edition of ... the week of March 23, the team reported ...
... leading provider of autism services shares events that raise ... Autism is the fastest-growing developmental disability in the ... a child is diagnosed with an autism spectrum disorder. ... and AIDS combined. It is one of our community,s ...
... LCG Associates, a national investment consulting firm, ... L. Bentley, CFA, CAIA.LCG,s ownership provides significant incentive ... the consulting industry. LCG rewards ownership in ... commitment to excellence and honesty.LCG Associates, Inc. provides ...
... School Children , ... St. Cloud, Minn. (Vocus) March ... dental program to St. Cloud Area School District 742 public elementary ... health of low-income and uninsured children. Smiles Across Minnesota provides children ...
... Is Urgent; Among Seniors with Diabetes, Half Are Unaware; Medicare,s ... City Councilors Nancy White, RN, Charles Jones, and Ed ... Macon area seniors to learn more about their personal risk ... (MDSP) in Macon before a crowd gathered in front of ...
Cached Medicine News:Health News:NIH will use $60 million in Recovery Act funds to support strategic autism research 2Health News:NIH will use $60 million in Recovery Act funds to support strategic autism research 3Health News:April is Autism Awareness Month 2Health News:April is Autism Awareness Month 3Health News:Smiles Across Minnesota Expands Program to St. Cloud 2Health News:Smiles Across Minnesota Expands Program to St. Cloud 3Health News:Smiles Across Minnesota Expands Program to St. Cloud 4Health News:City Councilors Nancy White, RN, Charles Jones, and Ed DeFore Launch Medicare Diabetes Screening Project in Macon 2Health News:City Councilors Nancy White, RN, Charles Jones, and Ed DeFore Launch Medicare Diabetes Screening Project in Macon 3
... is lightweight enough to shuttle easily between ... Designed with a goldmann standard 30 cm ... with 79 locations (including 30-2, 24-2, and ... different suprathresholds out to 30. Easyfield ...
... detections of any possible ... glaucoma in the visual ... Smooth operation of kinetic ... accuracy of static and ...
Focus Toric Monthly lenses. All the advantages of Focus Monthly lenses, now available for patients with astigmatism. Recommended for daily wear. Also approved for extended wear (1-7 days)....
Preference Toric quarterly planned replacement lenses are durable, easy to handle and virtually maintenance free. Meeting the needs of those suffering from astigmatism, these soft contact lenses are ...
Medicine Products: